To identify the molecule responsible for the oncogenic role of MARCH6 in thyroid cancer, immunoblotting assays were performed in K1, TPC-1 and BCPAP cells with low and high MARCH6 expression. This evidence concerns the gene MARCHF6 and thyroid gland carcinoma.